NCT03226119 - MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

July 10, 2018

Study Completion Date

August 31, 2018

Conditions

HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1Human T-lymphotropic Virus 2HTLV I Associated T Cell Leukemia LymphomaHTLV I Associated Myelopathies

Interventions

DIAGNOSTIC_TEST

MP Diagnostics HTLV Blot 2.4

HTLV I/II Confirmation and Differentiation

Trial Locations (3)

19123

LABS, Inc., Philadelphia

23507

Eastern Virginia Medical School (EVMS), Norfolk

78201

Qualtex Laboratories, San Antonio